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questionnaires were completed. Medical cen-
ters differed regarding the referral level—aca-
demic or nonacademic (provincial, district, or re-
gional). The survey was anonymous, voluntary, 
conducted electronically, and regarded the first 
3 months of the pandemic. It included 26 single- 
or multiple -choice questions. Only a single re-
spondent or a person authorized by them was 
allowed to fill in the questionnaire in each cen-
ter. Additional bioethics committee approval 
was not required.
Statistical analysis The obtained data were sub-
jected to statistical analysis. Categorical vari-
ables were presented as percentages. Statisti-
cal significance for individual study groups was 
not evaluated.
Results and discussion Selected results of 
the survey are presented in TABLE 1. The question-
naire was completed by 18 academic and 18 non-
academic centers, including 5 outpatient clin-
ics and 5 private healthcare centers. In 89% of 
the centers, a cardiology outpatient clinic was 
available on site. According to the reported data, 
the number of hospitalizations due to HF in ac-
ademic, provincial, or district centers was low-
er during the pandemic than earlier, while in 
regional centers somewhat similar to that not-
ed before the pandemic. The centers widely of-
fered teleconsultations (83%); in -person visits, 
if necessary, were scarce (5.5%), regardless of 
Introduction On March 11, 2020, the World 
Health Organization declared the outbreak of coro-
navirus disease 2019 (COVID-19) to be a pandemic.1 
Since March 4, 2020, 36 155 Polish patients were in-
fected by severe acute respiratory syndrome coro-
navirus 2 (SARS -CoV-2).2 The risk of SARS -CoV-2 
transmission may be higher in patients with heart 
failure (HF) and also increased due to comorbidities 
and advanced age.3 In the current European Soci-
ety of Cardiology Guidance for the diagnosis and man‑
agement of cardiovascular disease during the COVID‑19 
pandemic, it is recommended to refrain from hospital 
visits and to use guideline -directed medical therapy 
and telemedicine, whenever possible, to follow up 
stable patients with HF.3 During the COVID-19 pan-
demic, Jiménez -Blanco Bravo et al4 showed a 56.5% 
reduction in the number of emergency room visits 
and a 46.9% reduction in hospital admissions of pa-
tients with HF in Spain. Similarly, Bromage et al5 
confirmed fewer HF patient admissions to cardiol-
ogy units in 2020 compared with 2019 in the Unit-
ed Kingdom (23% vs 37%, respectively), and the pa-
tients admitted during the COVID-19 pandemic pre-
sented with a higher New York Heart Association 
(NYHA) class and severe peripheral edema.
This study aimed to obtain data on the care of 
patients with HF in Polish medical centers dur-
ing the COVID-19 pandemic.
Methods We developed a survey and sent it 
by e mail in June 2020 to most Polish medical 
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TABLE 1 Selected healthcare components in 36 Polish medical centers during the coronavirus disease 2019 outbreak according to the referral 
level, based on a survey (continued on the next page)
Academic centers (n = 18) Nonacademic centers (n = 18)
Center characteristic
Inpatient clinic 15 11
Outpatient clinic 3 2
Private healthcare center – 5
Unit profile
Cardiology 18 10
Internal medicine – 3
Primary healthcare – 5




Hospitalizations due to acute HF during the pandemic, n
As many as before the pandemic 6 8
Less than before the pandemic 10 9
No such hospitalizations 2 1




β ‑Blocker 16 15
MRA 11 10
Loop diuretic 16 18
Ivabradine 2 4
Digoxin – 2




No new drug administration 7 8










Not applicable (noninvasive center) 2 11
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therapy modification (eg, mechanical valve pros-
thesis), as well as from a limited access to labo-
ratories and data on serum creatinine levels and 
international normalized ratio before switching 
from vitamin K antagonists to non–vitamin K 
oral anticoagulants.
Surprisingly, the question less frequently 
asked to assess the patient’s clinical status con-
cerned their body weight (25/36), while ques-
tions regarding the NYHA status, edema of low-
er extremities, or blood pressure and heart rate 
were more frequent (32/36, 34/36, and 33/36, 
respectively).
Finally, patient education regarding HF man-
agement was provided in 69% of the centers and 
conducted by physicians (92%) or nurses (8%, 
only in academic centers). Educators relied on 
their knowledge (100%), and additional tools, 
such as web pages or mobile phone applications, 
were rarely used (32%). Among the surveyed 
centers, 86% expressed concern about the neg-
ative impact of the pandemic on the HF popu-
lation, while 61% indicated that teleconsulta-
tions would partially replace in -person visits 
after the pandemic.
Limitations Our study had some limitations. 
First, it included a relatively small number of 
centers nationwide. Next, it was focused on gen-
eral trends in HF management in certain centers, 
and not on patient -centered care. The study also 
regarded only the first 3 months of the pandem-
ic and did not determine the long -term impact 
of the pandemic on HF prognosis. Also, the sur-
vey did not cover all issues related to the care of 
HF patients (eg, exercise, rehabilitation). Admit-
tedly, it might be much more broadly elaborat-
ed in an original research article.
Conclusions The  epidemiological situation 
seems to be unpredictable, and the pandemic 
appears to be long -lasting. Teleconsultations, 
the center referral level. These 2 forms of visits 
were not available in 11% of the centers.
Additional diagnostic procedures such as 
echocardiography, 24-hour electrocardiogram 
monitoring, cardiac magnetic resonance, or 
cardiac computed tomography angiography 
were used in 72% of the centers, but mainly in 
non-new patients with chronic HF. In general, 
invasive procedures were performed less fre-
quently than before the pandemic.
A teleconsultation for new patients with HF 
as the only form of medical visit was provided 
in 33% of the centers. Before teleconsultations 
were implemented, up to 5% of the HF popula-
tion was hospitalized due to HF decompensa-
tion in the pandemic period. Although, at the 
time of the use of teleconsultations, in 64% of 
the centers, patients required referral to a hos-
pital due to HF exacerbation.
In 92% of the centers, e -prescriptions were 
issued. The most commonly prescribed drugs 
were: loop diuretics (torasemide, furosemide), 
angiotensin -converting enzyme inhibitors, 
and β -blockers, whereas the least popular pre-
scribed drugs included: angiotensin receptor 
neprilysin inhibitors, ivabradine, and digox-
in (TABLE 1). Peripheral edema was the most crit-
ical symptom for the modification of diuretic 
treatment. Of note, both angiotensin receptor 
neprilysin inhibitors and ivabradine were ad-
ministered only in the cardiology units of re-
gional or academic centers, and digoxin was 
administered both in the cardiology units and 
primary healthcare clinics of district centers. 
In 42% of the centers, patients’ therapy was 
not modified.
Switching from vitamin K antagonists to non–
vitamin K oral anticoagulants was unexpected-
ly rare (10/36) and more common in provincial 
(2/3) and district (4/7) rather than in academ-
ic or regional centers (4/26). The low switching 
rate might result from contraindications to such 
TABLE 1 Selected healthcare components in 36 Polish medical centers during the coronavirus disease 2019 outbreak according to the referral 
level, based on a survey (continued from the previous page)




Interventional cardiac procedures (ICA, PCI)
Performed like before the pandemic 6 5
Occasional 10 –
Suspended – 1
Not applicable (noninvasive center) 2 12
Abbreviations: ACEI, angiotensin ‑converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor neprilysin inhibitor; CIED, cardiac 
implantable electronic device; CRT, cardiac resynchronization therapy; ICA, invasive coronary angiography; ICD, implantable cardioverter ‑defibrillator; 
MRA, mineralocorticoid receptor antagonist; NOAC, non–vitamin K oral anticoagulant; PCI, percutaneous coronary intervention; VKA, vitamin K antagonist
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mobile phone applications, and self -monitoring 
play a key role during the COVID-19 outbreak.6 
The presented results of the HF survey carried 
out in Polish centers are similar to those ob-
tained in other European countries. Following 
the national lockdown and social distancing 
restrictions, a lower access to healthcare and 
highly specialized procedures in patients with 
HF and a decrease in the number of hospitaliza-
tions due to acute HF might have an impact on 
HF prognosis. Similarly, Legutko et al7 report-
ed a decline in the number of coronary angiog-
raphy and percutaneous coronary intervention 
procedures in Polish patients with myocardi-
al infarction during the COVID-19 pandemic.7 
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